Professor Kristoffer Hellstrand to present new Ceplene data at the American Society of Hematology

December 2nd, 2019

"Complete Remission after the First Cycle of Induction Chemotherapy Determines the Clinical Efficacy of Relapse-Preventive Immunotherapy in Acute Myeloid Leukemia"


Program: Oral and Poster Abstracts
Session: 613. Acute Myeloid Leukemia: Clinical Studies: Poster I
Hematology Disease Topics & Pathways:
Biological, AML, Diseases, Therapies, immunotherapy, Myeloid Malignancies

Saturday, December 7, 2019, 5:30 PM-7:30 PM

Hall B, Level 2 (Orange County Convention Center)

 

Subscribe Form

  • Facebook
  • Twitter
  • LinkedIn